Ye JM - Search Results

1

Repurposing Drugs to Target the Diabetes Epidemic.

Turner N, Zeng XY, Osborne B, Rogers S, Ye JM. Turner N, et al. Among authors: ye jm. Trends Pharmacol Sci. 2016 May;37(5):379-389. doi: 10.1016/j.tips.2016.01.007. Epub 2016 Feb 18. Trends Pharmacol Sci. 2016. PMID: 26900045 Review.

2

Screening for the efficacy on lipid accumulation in 3T3-L1 cells is an effective tool for the identification of new anti-diabetic compounds.

Zeng XY, Zhou X, Xu J, Chan SM, Xue CL, Molero JC, Ye JM. Zeng XY, et al. Among authors: ye jm. Biochem Pharmacol. 2012 Sep 15;84(6):830-7. doi: 10.1016/j.bcp.2012.07.003. Epub 2012 Jul 20. Biochem Pharmacol. 2012. PMID: 22820245 Free article.

3

Liver glycogen in type 2 diabetic mice is randomly branched as enlarged aggregates with blunted glucose release.

Besford QA, Zeng XY, Ye JM, Gray-Weale A. Besford QA, et al. Among authors: ye jm. Glycoconj J. 2016 Feb;33(1):41-51. doi: 10.1007/s10719-015-9631-5. Epub 2015 Oct 31. Glycoconj J. 2016. PMID: 26521055

4

Repurposing matrine for the treatment of hepatosteatosis and associated disorders in glucose homeostasis in mice.

Mahzari A, Zeng XY, Zhou X, Li S, Xu J, Tan W, Vlahos R, Robinson S, Ye JM. Mahzari A, et al. Among authors: ye jm. Acta Pharmacol Sin. 2018 Nov;39(11):1753-1759. doi: 10.1038/s41401-018-0016-8. Epub 2018 Jul 6. Acta Pharmacol Sin. 2018. PMID: 29980742 Free PMC article.

5

PPARδ agonists have opposing effects on insulin resistance in high fat-fed rats and mice due to different metabolic responses in muscle.

Ye JM, Tid-Ang J, Turner N, Zeng XY, Li HY, Cooney GJ, Wulff EM, Sauerberg P, Kraegen EW. Ye JM, et al. Br J Pharmacol. 2011 Jun;163(3):556-66. doi: 10.1111/j.1476-5381.2011.01240.x. Br J Pharmacol. 2011. PMID: 21265823 Free PMC article.

6

Activation of AMPK by bitter melon triterpenoids involves CaMKKβ.

Iseli TJ, Turner N, Zeng XY, Cooney GJ, Kraegen EW, Yao S, Ye Y, James DE, Ye JM. Iseli TJ, et al. Among authors: ye jm, ye y. PLoS One. 2013 Apr 25;8(4):e62309. doi: 10.1371/journal.pone.0062309. Print 2013. PLoS One. 2013. PMID: 23638033 Free PMC article.

7

Differing endoplasmic reticulum stress response to excess lipogenesis versus lipid oversupply in relation to hepatic steatosis and insulin resistance.

Ren LP, Chan SM, Zeng XY, Laybutt DR, Iseli TJ, Sun RQ, Kraegen EW, Cooney GJ, Turner N, Ye JM. Ren LP, et al. Among authors: ye jm. PLoS One. 2012;7(2):e30816. doi: 10.1371/journal.pone.0030816. Epub 2012 Feb 15. PLoS One. 2012. PMID: 22355328 Free PMC article.

8

Oleanolic acid reduces hyperglycemia beyond treatment period with Akt/FoxO1-induced suppression of hepatic gluconeogenesis in type-2 diabetic mice.

Zeng XY, Wang YP, Cantley J, Iseli TJ, Molero JC, Hegarty BD, Kraegen EW, Ye Y, Ye JM. Zeng XY, et al. Among authors: ye jm, ye y. PLoS One. 2012;7(7):e42115. doi: 10.1371/journal.pone.0042115. Epub 2012 Jul 30. PLoS One. 2012. PMID: 22860063 Free PMC article.

9

Activation of PPARα ameliorates hepatic insulin resistance and steatosis in high fructose-fed mice despite increased endoplasmic reticulum stress.

Chan SM, Sun RQ, Zeng XY, Choong ZH, Wang H, Watt MJ, Ye JM. Chan SM, et al. Among authors: ye jm. Diabetes. 2013 Jun;62(6):2095-105. doi: 10.2337/db12-1397. Epub 2013 Jan 24. Diabetes. 2013. PMID: 23349482 Free PMC article.

10

Hepatic FoxO1 acetylation is involved in oleanolic acid-induced memory of glycemic control: novel findings from Study 2.

Zhou X, Zeng XY, Wang H, Li S, Jo E, Xue CC, Tan M, Molero JC, Ye JM. Zhou X, et al. Among authors: ye jm. PLoS One. 2014 Sep 15;9(9):e107231. doi: 10.1371/journal.pone.0107231. eCollection 2014. PLoS One. 2014. PMID: 25222566 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

198 results

Search Page